Cross Country Healthcare (NASDAQ:CCRN) Issues Earnings Results

Cross Country Healthcare (NASDAQ:CCRN) issued its earnings results on Wednesday. The business services provider reported $0.01 earnings per share (EPS) for the quarter, reports. The company had revenue of $202.80 million during the quarter, compared to analyst estimates of $199.46 million. Cross Country Healthcare had a positive return on equity of 1.19% and a negative net margin of 2.54%. The firm’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter last year, the business posted $0.05 EPS. Cross Country Healthcare updated its Q3 guidance to $0.00-$0.02 EPS.

Shares of NASDAQ CCRN traded down $0.38 during trading on Friday, reaching $9.25. 211,730 shares of the company traded hands, compared to its average volume of 198,558. The company has a fifty day moving average price of $9.03. The firm has a market cap of $357.58 million, a PE ratio of 77.08, a P/E/G ratio of 18.87 and a beta of 1.24. Cross Country Healthcare has a 12-month low of $6.75 and a 12-month high of $10.27. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.08 and a current ratio of 2.08.

In related news, CEO Kevin Cronin Clark acquired 8,330 shares of Cross Country Healthcare stock in a transaction on Friday, June 14th. The stock was acquired at an average price of $8.00 per share, for a total transaction of $66,640.00. Following the purchase, the chief executive officer now owns 250,734 shares of the company’s stock, valued at approximately $2,005,872. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 3.80% of the company’s stock.

CCRN has been the subject of a number of research analyst reports. Zacks Investment Research lowered Cross Country Healthcare from a “buy” rating to a “hold” rating in a research note on Friday. Barrington Research set a $10.00 price objective on Cross Country Healthcare and gave the company a “buy” rating in a research note on Monday, May 20th. BidaskClub upgraded Cross Country Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 27th. Finally, ValuEngine upgraded Cross Country Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $9.80.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Featured Story: Are 12b-1 Fees Affecting Your Mutual Fund Performance?

Earnings History for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with's FREE daily email newsletter.